This is in accordance with the previously published data that showed the potential predictive significance of cetuximab-induced ADCC activity exerted by CD56+CD3− NK cells isolated from peripheral blood of patients with metastatic colorectal cancer (11). Here, NCAM1 is linked to metastatic colorectal cancer.